The first hints of any kind of tumor-suppressive function for KLF9 were reported in 2008 and 2011; in these reports, KLF9 mRNA and protein levels were shown to be significantly reduced in human endometrial tumors when compared to adjacent uninvolved endometrium [31,32]. The gene discussed is KLF9; the disease is endometrium neoplasm.